Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma.
Suksawat M, Phetcharaburanin J, Klanrit P, Namwat N, Khuntikeo N, Titapun A, Jarearnrat A, Vilayhong V, Sa-Ngiamwibool P, Techasen A, Wangwiwatsin A, Mahalapbutr P, Li JV, Loilome W. Suksawat M, et al. Among authors: phetcharaburanin j. Front Public Health. 2022 Feb 10;10:766023. doi: 10.3389/fpubh.2022.766023. eCollection 2022. Front Public Health. 2022. PMID: 35223723 Free PMC article.
Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis.
Duangkumpha K, Stoll T, Phetcharaburanin J, Yongvanit P, Thanan R, Techasen A, Namwat N, Khuntikeo N, Chamadol N, Roytrakul S, Mulvenna J, Mohamed A, Shah AK, Hill MM, Loilome W. Duangkumpha K, et al. Among authors: phetcharaburanin j. J Proteome Res. 2019 Sep 6;18(9):3305-3316. doi: 10.1021/acs.jproteome.9b00242. Epub 2019 Jul 31. J Proteome Res. 2019. PMID: 31310545
Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis.
Duangkumpha K, Stoll T, Phetcharaburanin J, Yongvanit P, Thanan R, Techasen A, Namwat N, Khuntikeo N, Chamadol N, Roytrakul S, Mulvenna J, Mohamed A, Shah AK, Hill MM, Loilome W. Duangkumpha K, et al. Among authors: phetcharaburanin j. PLoS One. 2019 Aug 19;14(8):e0221024. doi: 10.1371/journal.pone.0221024. eCollection 2019. PLoS One. 2019. PMID: 31425520 Free PMC article.
In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues.
Suksawat M, Klanrit P, Phetcharaburanin J, Namwat N, Khuntikeo N, Titapun A, Jarearnrat A, Sa-Ngiamwibool P, Techasen A, Loilome W. Suksawat M, et al. Among authors: phetcharaburanin j. PLoS One. 2019 Sep 10;14(9):e0222140. doi: 10.1371/journal.pone.0222140. eCollection 2019. PLoS One. 2019. PMID: 31504065 Free PMC article.
Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma.
Padthaisong S, Thanee M, Namwat N, Phetcharaburanin J, Klanrit P, Khuntikeo N, Titapun A, Sungkhamanon S, Saya H, Loilome W. Padthaisong S, et al. Among authors: phetcharaburanin j. J Transl Med. 2020 Feb 10;18(1):64. doi: 10.1186/s12967-020-02243-w. J Transl Med. 2020. PMID: 32039729 Free PMC article.
49 results